Sh Fosun Pharma | 600196 - Ebitda

Stock Price
26.70
Daily Change
-0.36 -1.33%
Monthly
6.76%
Yearly
15.09%
Q2 Forecast
26.07

Sh Fosun Pharma reported CNY1.69B in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Jiangsu Hengrui CNY 2.98B 890.87M Jun/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 5.71B 1.36B Jun/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025